Skip to content

HINTEGRA Total Ankle Prosthesis Follow-up

Short to Mid Term Follow-up of Patient Implanted With the HINTEGRA® Total Ankle Prosthesis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01284972
Enrollment
225
Registered
2011-01-27
Start date
2009-02-28
Completion date
2010-12-31
Last updated
2012-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Ankle Prosthesis

Brief summary

The Hintegra® Total Ankle Prosthesis is a non constrained, three-component prosthesis that consists of a flat tibial component, an anatomically-shaped talar component, and a high-density polyethylene inlay. The Hintegra ankle was specifically developed as an attempt to address the needs of minimal bone resection, extended bone support, proper ligament balancing, and minimal contact stressed within and around the prosthesis. The objective of this study is to evaluate the safety and efficacy of the HINTEGRA® Total Ankle prosthesis at short and mid term follow up.

Interventions

None listed

Sponsors

Integra LifeSciences Services
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient implanted with an Hintegra® Total Ankle Prosthesis (only prosthesis designed with pegs) in primary ankle surgery since a minimum of 2 years * Age ≥ 18 years * Have willingness to give his/her data transfer authorisation

Exclusion criteria

* History of prior mental illness or patient demonstrates that their mental capacity may interfere with their ability to follow the study protocol

Design outcomes

Primary

MeasureTime frame
rate of device related complications at the follow up after 2 years of implantationmore than 2 years after the implantation

Secondary

MeasureTime frame
AOFAS Ankle-Hindfoot Scale score (American Orthopaedic Foot and Ankle Society).more than 2 years after the implantation

Countries

Austria, Canada, France, Germany, South Korea, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026